Symbol:
Cyp2a4
Name:
cytochrome P450, family 2, subfamily a, polypeptide 4
RGD ID:
1624100
MGI Page
MGI
Description:
Predicted to enable enzyme binding activity; heme binding activity; and monooxygenase activity. Involved in response to stilbenoid. Predicted to be located in cytoplasmic microtubule. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in liver; lung; metanephros; nervous system; and nose. Orthologous to several human genes including CYP2A13 (cytochrome P450 family 2 subfamily A member 13) and CYP2A6 (cytochrome P450 family 2 subfamily A member 6).
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
AI893559; Cyp15; Cyp15a1; CYPIIA4; cytochrome P450 2A4; cytochrome P450, 2a4; cytochrome P450-15-alpha; cytochrome P450-IIA3.1; D7Ucl; D7Ucla4; testosterone 15-alpha-hydroxylase; testosterone 15alpha-hydroxylase
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CYP2A7 (cytochrome P450 family 2 subfamily A member 7)
HGNC
Ensembl, HomoloGene, Inparanoid, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):
Cyp2a3 (cytochrome P450, family 2, subfamily a, polypeptide 3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
CYP2A6 (cytochrome P450 family 2 subfamily A member 6)
HGNC
Ensembl, HomoloGene, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Homo sapiens (human):
CYP2A13 (cytochrome P450 family 2 subfamily A member 13)
HGNC
Ensembl, HomoloGene, OMA, OrthoDB, OrthoMCL, Treefam
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Cyp2a3 (cytochrome P450, family 2, subfamily a, polypeptide 3)
Alliance
DIOPT (Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
CYP2A6 (cytochrome P450 family 2 subfamily A member 6)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
CYP2A13 (cytochrome P450 family 2 subfamily A member 13)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Homo sapiens (human):
CYP2A7 (cytochrome P450 family 2 subfamily A member 7)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OrthoFinder|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp2y3 (cytochrome P450, family 2, subfamily Y, polypeptide 3)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
DIT2
Alliance
DIOPT (Ensembl Compara|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33A1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33C9
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33D1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33D3
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33B1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-23A1
Alliance
DIOPT (Hieranoid|OMA|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-34A7
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A1
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A5
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A6
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A8
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35A3
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35B1
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35B2
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A10
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A2
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A9
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35A5
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35A4
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35A2
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35C1
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35B3
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35A1
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Xenopus tropicalis (tropical clawed frog):
cyp2a6.8
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
cyp2a6.9
Alliance
DIOPT (OMA|OrthoFinder|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
cyp2a13l
Alliance
DIOPT (OMA|OrthoFinder|PANTHER|PhylomeDB)
Related Pseudogenes:
Cyp2a21-ps
Latest Assembly:
GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 7 26,006,617 - 26,014,513 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 7 26,006,594 - 26,014,513 (+) Ensembl GRCm39 Ensembl GRCm38 7 26,307,192 - 26,315,088 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 7 26,307,169 - 26,315,088 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 7 27,092,211 - 27,100,107 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 7 26,015,952 - 26,023,848 (+) NCBI MGSCv36 mm8 Celera 7 20,896,679 - 20,902,855 (+) NCBI Celera Cytogenetic Map 7 A3 NCBI cM Map 7 14.39 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cyp2a4 Mouse (-)-anisomycin multiple interactions EXP 6480464 1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [[Anisomycin co-treated with NR1I3 protein] results in increased expression of CYP2A7 more ... CTD PMID:23539296 Cyp2a4 Mouse (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2A4 mRNA CTD PMID:36331819 Cyp2a4 Mouse (S)-nicotine increases expression ISO RGD:2465 6480464 Nicotine results in increased expression of CYP2A3 mRNA CTD PMID:14972772|PMID:22934830 Cyp2a4 Mouse 1,2-dimethylhydrazine decreases expression EXP 6480464 1,2-Dimethylhydrazine results in decreased expression of CYP2A4 mRNA CTD PMID:22206623 Cyp2a4 Mouse 17beta-estradiol increases metabolic processing EXP 6480464 CYP2A4 protein results in increased metabolism of Estradiol CTD PMID:10490589 Cyp2a4 Mouse 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP2A4 mRNA CTD PMID:39298647 Cyp2a4 Mouse 17beta-estradiol affects expression ISO RGD:2465 6480464 Estradiol affects the expression of CYP2A3 mRNA CTD PMID:32145629 Cyp2a4 Mouse 17beta-estradiol decreases expression ISO RGD:1353273 6480464 Estradiol results in decreased expression of CYP2A7 mRNA CTD PMID:20106945 Cyp2a4 Mouse 1H-pyrazole increases expression ISO RGD:2465 6480464 pyrazole results in increased expression of CYP2A3 mRNA CTD PMID:12845369 Cyp2a4 Mouse 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased more ... CTD PMID:28433925 Cyp2a4 Mouse 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:2465 6480464 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP2A3 mRNA CTD PMID:31826744 Cyp2a4 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CYP2A4 mRNA; [Tetrachlorodibenzodioxin co-treated more ... CTD PMID:16214954|PMID:28213091|PMID:28433925|PMID:34129049 Cyp2a4 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2465 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2A3 mRNA CTD PMID:21215274 Cyp2a4 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1353273 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP2A7 mRNA CTD PMID:26159488 Cyp2a4 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2A4 mRNA CTD PMID:28213091 Cyp2a4 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2A4 mRNA CTD PMID:28922406 Cyp2a4 Mouse 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity EXP 6480464 Verapamil results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse 3-methylcholanthrene multiple interactions ISO RGD:1353273 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to CYP2A7 promoter] CTD PMID:20348232 Cyp2a4 Mouse 3-methylcholanthrene increases expression ISO RGD:2465 6480464 Methylcholanthrene results in increased expression of CYP2A3 mRNA CTD PMID:12845369|PMID:22934830 Cyp2a4 Mouse 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of CYP2A4 mRNA CTD PMID:30503582 Cyp2a4 Mouse 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of CYP2A4 mRNA CTD PMID:33297965|PMID:39298647 Cyp2a4 Mouse 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of CYP2A4 mRNA CTD PMID:30503582 Cyp2a4 Mouse 5-methoxyindole decreases activity EXP 6480464 5-methoxyindole results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse aflatoxin B1 decreases expression ISO RGD:1353273 6480464 Aflatoxin B1 results in decreased expression of CYP2A7 mRNA CTD PMID:27153756|PMID:32234424 Cyp2a4 Mouse aflatoxin B1 affects expression ISO RGD:1353273 6480464 Aflatoxin B1 affects the expression of CYP2A7 protein CTD PMID:20106945 Cyp2a4 Mouse aflatoxin B1 decreases methylation ISO RGD:1353273 6480464 Aflatoxin B1 results in decreased methylation of CYP2A7 gene CTD PMID:27153756 Cyp2a4 Mouse alachlor decreases expression ISO RGD:2465 6480464 alachlor results in decreased expression of CYP2A3 protein CTD PMID:16698726 Cyp2a4 Mouse all-trans-retinoic acid decreases activity EXP 6480464 Tretinoin results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse ammonium chloride affects expression ISO RGD:2465 6480464 Ammonium Chloride affects the expression of CYP2A3 mRNA CTD PMID:16483693 Cyp2a4 Mouse andrographolide increases expression EXP 6480464 andrographolide results in increased expression of CYP2A4 mRNA CTD PMID:19737545 Cyp2a4 Mouse andrographolide multiple interactions EXP 6480464 beta-Naphthoflavone promotes the reaction [andrographolide results in increased expression of CYP2A4 mRNA] CTD PMID:19737545 Cyp2a4 Mouse Aroclor 1254 increases expression ISO RGD:1353273 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2A7 mRNA CTD PMID:17851650 Cyp2a4 Mouse arsane increases expression EXP 6480464 Arsenic results in increased expression of CYP2A4 mRNA CTD PMID:15026472 Cyp2a4 Mouse arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of CYP2A4 mRNA CTD PMID:15026472 Cyp2a4 Mouse arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of CYP2A4 mRNA CTD PMID:18991936 Cyp2a4 Mouse atrazine increases expression EXP 6480464 Atrazine results in increased expression of CYP2A4 mRNA CTD PMID:26775023 Cyp2a4 Mouse atrazine affects expression EXP 6480464 Atrazine affects the expression of CYP2A4 mRNA CTD PMID:36216167 Cyp2a4 Mouse atrazine multiple interactions EXP 6480464 Lycopene affects the reaction [Atrazine affects the expression of CYP2A4 mRNA]; Lycopene inhibits the reaction more ... CTD PMID:26775023|PMID:36216167 Cyp2a4 Mouse benzene decreases expression EXP 6480464 Benzene results in decreased expression of CYP2A4 mRNA CTD PMID:34624356 Cyp2a4 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP2A4 mRNA; Benzo(a)pyrene results in increased expression of CYP2A4 more ... CTD PMID:32417428|PMID:34472326 Cyp2a4 Mouse benzo[a]pyrene increases methylation ISO RGD:1353273 6480464 Benzo(a)pyrene results in increased methylation of CYP2A7 5' UTR; Benzo(a)pyrene results in increased methylation of more ... CTD PMID:27901495 Cyp2a4 Mouse benzo[a]pyrene decreases expression ISO RGD:1353273 6480464 Benzo(a)pyrene results in decreased expression of CYP2A7 mRNA CTD PMID:20106945|PMID:32234424 Cyp2a4 Mouse beta-naphthoflavone multiple interactions EXP 6480464 beta-Naphthoflavone promotes the reaction [andrographolide results in increased expression of CYP2A4 mRNA] CTD PMID:19737545 Cyp2a4 Mouse bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of CYP2A4 more ... CTD PMID:28433925|PMID:33484791 Cyp2a4 Mouse bisphenol A multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased more ... CTD PMID:28433925 Cyp2a4 Mouse bisphenol A decreases expression ISO RGD:2465 6480464 bisphenol A results in decreased expression of CYP2A3 mRNA CTD PMID:34947998 Cyp2a4 Mouse bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP2A4 mRNA CTD PMID:33221593 Cyp2a4 Mouse bisphenol A affects expression ISO RGD:2465 6480464 bisphenol A affects the expression of CYP2A3 mRNA CTD PMID:32145629 Cyp2a4 Mouse bisphenol F decreases expression EXP 6480464 bisphenol F results in decreased expression of CYP2A4 mRNA CTD PMID:38685157 Cyp2a4 Mouse C60 fullerene increases expression ISO RGD:2465 6480464 fullerene C60 results in increased expression of CYP2A3 mRNA CTD PMID:19167457 Cyp2a4 Mouse caffeine decreases activity EXP 6480464 Caffeine results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse calcitriol multiple interactions ISO RGD:1353273 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CYP2A7 mRNA CTD PMID:21592394 Cyp2a4 Mouse calcitriol increases expression ISO RGD:1353273 6480464 Calcitriol results in increased expression of CYP2A7 mRNA CTD PMID:21592394 Cyp2a4 Mouse carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon analog affects the expression of CYP2A4 mRNA CTD PMID:25554681 Cyp2a4 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of CYP2A4 mRNA CTD PMID:25554681 Cyp2a4 Mouse chlorohydrocarbon multiple interactions ISO RGD:2465 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated more ... CTD PMID:30744511 Cyp2a4 Mouse cholesterol decreases activity EXP 6480464 Cholesterol results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse cholic acid increases expression EXP 6480464 Cholic Acid results in increased expression of CYP2A4 mRNA CTD PMID:17521389 Cyp2a4 Mouse cobalt atom decreases expression ISO RGD:2465 6480464 Cobalt results in decreased expression of CYP2A3 mRNA CTD PMID:22198552 Cyp2a4 Mouse cobalt atom multiple interactions ISO RGD:2465 6480464 [Nickel co-treated with Cobalt co-treated with Tungsten] results in decreased expression of CYP2A3 mRNA; [Nickel more ... CTD PMID:22198552 Cyp2a4 Mouse cyclophosphamide decreases activity EXP 6480464 Cyclophosphamide results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse cyclosporin A decreases expression ISO RGD:1353273 6480464 Cyclosporine results in decreased expression of CYP2A7 mRNA CTD PMID:20106945 Cyp2a4 Mouse cylindrospermopsin increases expression EXP 6480464 cylindrospermopsin results in increased expression of CYP2A4 mRNA CTD PMID:20936652 Cyp2a4 Mouse cypermethrin increases expression ISO RGD:1353273 6480464 cypermethrin results in increased expression of CYP2A4 mRNA CTD PMID:22310298 Cyp2a4 Mouse daidzein decreases activity EXP 6480464 daidzein results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse dextromethorphan decreases activity EXP 6480464 Dextromethorphan results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse dibenzofurans decreases expression EXP 6480464 Dibenzofurans results in decreased expression of CYP2A4 mRNA CTD PMID:34254344 Cyp2a4 Mouse dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of CYP2A4 mRNA CTD PMID:28962523 Cyp2a4 Mouse diclofenac decreases activity EXP 6480464 Diclofenac results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse diclofenac affects expression EXP 6480464 Diclofenac affects the expression of CYP2A4 mRNA CTD PMID:26934552 Cyp2a4 Mouse diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CYP2A4 mRNA CTD PMID:16452187|PMID:19665456 Cyp2a4 Mouse diethylstilbestrol multiple interactions EXP 6480464 [Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of CYP2A4 mRNA; sodium arsenite promotes more ... CTD PMID:16452187|PMID:19665456 Cyp2a4 Mouse dihydroergotamine decreases activity EXP 6480464 Dihydroergotamine results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse diquat decreases expression EXP 6480464 Diquat results in decreased expression of CYP2A4 protein CTD PMID:36851058 Cyp2a4 Mouse doramapimod increases expression EXP 6480464 doramapimod results in increased expression of CYP2A4 mRNA CTD PMID:21328587 Cyp2a4 Mouse endosulfan multiple interactions ISO RGD:1353273 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP2A7 mRNA CTD PMID:26159488 Cyp2a4 Mouse endosulfan increases expression ISO RGD:2465 6480464 Endosulfan results in increased expression of CYP2A3 mRNA CTD PMID:29391264 Cyp2a4 Mouse epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of CYP2A4 mRNA CTD PMID:35436446 Cyp2a4 Mouse ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP2A4 mRNA CTD PMID:19167417 Cyp2a4 Mouse ethanol decreases expression ISO RGD:2465 6480464 Ethanol results in decreased expression of CYP2A3 mRNA CTD PMID:16098508 Cyp2a4 Mouse farnesol increases activity ISO RGD:2465 6480464 Farnesol results in increased activity of CYP2A3 protein CTD PMID:15840382 Cyp2a4 Mouse fenofibrate multiple interactions ISO RGD:2465 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CYP2A3 mRNA CTD PMID:18253720 Cyp2a4 Mouse fipronil multiple interactions ISO RGD:1353273 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2A7 mRNA CTD PMID:27091632 Cyp2a4 Mouse fumonisin B1 increases expression EXP 6480464 fumonisin B1 results in increased expression of CYP2A4 mRNA CTD PMID:16221962 Cyp2a4 Mouse furan increases expression EXP 6480464 furan results in increased expression of CYP2A4 mRNA CTD PMID:24183702|PMID:37517673 Cyp2a4 Mouse glyphosate decreases expression EXP 6480464 Glyphosate results in decreased expression of CYP2A4 protein CTD PMID:37208198 Cyp2a4 Mouse griseofulvin affects expression EXP 6480464 Griseofulvin affects the expression of CYP2A4 mRNA CTD PMID:12735108 Cyp2a4 Mouse hexachlorobenzene increases expression ISO RGD:2465 6480464 Hexachlorobenzene results in increased expression of CYP2A3 mRNA CTD PMID:15159207 Cyp2a4 Mouse hydralazine multiple interactions ISO RGD:1353273 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of CYP2A7 mRNA CTD PMID:17183730 Cyp2a4 Mouse isoproturon decreases activity EXP 6480464 isoproturon results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse ivermectin decreases activity EXP 6480464 Ivermectin results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse Lasiocarpine decreases expression ISO RGD:1353273 6480464 lasiocarpine results in decreased expression of CYP2A7 mRNA CTD PMID:32234424 Cyp2a4 Mouse lithocholic acid decreases activity EXP 6480464 Lithocholic Acid results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse lycopene multiple interactions EXP 6480464 Lycopene affects the reaction [Atrazine affects the expression of CYP2A4 mRNA]; Lycopene inhibits the reaction more ... CTD PMID:26775023|PMID:36216167 Cyp2a4 Mouse MeIQx multiple interactions ISO RGD:2465 6480464 CYP2A3 protein results in increased metabolism of and results in increased activity of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline CTD PMID:8403195 Cyp2a4 Mouse mephenytoin decreases activity EXP 6480464 Mephenytoin results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse methotrexate affects expression EXP 6480464 Methotrexate affects the expression of CYP2A4 mRNA CTD PMID:18502557 Cyp2a4 Mouse methoxsalen decreases activity EXP 6480464 Methoxsalen results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse methoxsalen decreases activity ISO RGD:2465 6480464 Methoxsalen results in decreased activity of CYP2A3 protein CTD PMID:15879494 Cyp2a4 Mouse methoxychlor decreases activity EXP 6480464 Methoxychlor results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse methylmercury chloride multiple interactions ISO RGD:2465 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated more ... CTD PMID:30744511 Cyp2a4 Mouse midazolam decreases activity EXP 6480464 Midazolam results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse N,N-diethyl-m-toluamide increases expression ISO RGD:1353273 6480464 DEET results in increased expression of CYP2A7 mRNA CTD PMID:27091632 Cyp2a4 Mouse N,N-diethyl-m-toluamide multiple interactions ISO RGD:1353273 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2A7 mRNA CTD PMID:27091632 Cyp2a4 Mouse N-nitrosodiethylamine multiple interactions ISO RGD:2465 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CYP2A3 mRNA CTD PMID:18253720 Cyp2a4 Mouse N-nitrosodimethylamine multiple interactions ISO RGD:1353273 6480464 CYP2A7 protein results in increased metabolism of and results in increased activity of Dimethylnitrosamine CTD PMID:11960914 Cyp2a4 Mouse N-Nitrosopyrrolidine decreases expression ISO RGD:1353273 6480464 N-Nitrosopyrrolidine results in decreased expression of CYP2A7 mRNA CTD PMID:32234424 Cyp2a4 Mouse nickel atom decreases expression ISO RGD:2465 6480464 Nickel results in decreased expression of CYP2A3 mRNA CTD PMID:22198552 Cyp2a4 Mouse nickel atom multiple interactions ISO RGD:2465 6480464 [Nickel co-treated with Cobalt co-treated with Tungsten] results in decreased expression of CYP2A3 mRNA; [Nickel more ... CTD PMID:22198552 Cyp2a4 Mouse nicotine increases expression ISO RGD:2465 6480464 Nicotine results in increased expression of CYP2A3 mRNA CTD PMID:14972772|PMID:22934830 Cyp2a4 Mouse nifedipine decreases activity EXP 6480464 Nifedipine results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse O-methyleugenol decreases expression ISO RGD:1353273 6480464 methyleugenol results in decreased expression of CYP2A7 mRNA CTD PMID:32234424 Cyp2a4 Mouse okadaic acid decreases expression ISO RGD:1353273 6480464 Okadaic Acid results in decreased expression of CYP2A7 mRNA CTD PMID:38832940 Cyp2a4 Mouse paraquat decreases expression ISO RGD:2465 6480464 Paraquat results in decreased expression of CYP2A3 mRNA CTD PMID:32680482 Cyp2a4 Mouse parathion increases expression EXP 6480464 Parathion results in increased expression of CYP2A4 mRNA CTD PMID:34813904 Cyp2a4 Mouse pentane-2,3-dione decreases expression ISO RGD:2465 6480464 2,3-pentanedione results in decreased expression of CYP2A3 mRNA CTD PMID:25710175 Cyp2a4 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2A4 mRNA; [perfluorooctane sulfonic more ... CTD PMID:36331819 Cyp2a4 Mouse perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP2A4 mRNA CTD PMID:18281256 Cyp2a4 Mouse perfluorooctanoic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of CYP2A4 mRNA] CTD PMID:18281256 Cyp2a4 Mouse phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP2A4 mRNA CTD PMID:20403969|PMID:30503582 Cyp2a4 Mouse phenobarbital increases expression ISO RGD:2465 6480464 Phenobarbital results in increased expression of CYP2A3 mRNA CTD PMID:22934830 Cyp2a4 Mouse phenobarbital increases expression ISO RGD:1353273 6480464 Phenobarbital results in increased expression of CYP2A7 mRNA CTD PMID:19084549 Cyp2a4 Mouse pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CYP2A4 mRNA CTD PMID:15375163 Cyp2a4 Mouse pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP2A4 mRNA CTD PMID:16221962|PMID:20813756|PMID:23811191 Cyp2a4 Mouse potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of CYP2A4 mRNA CTD PMID:23608068 Cyp2a4 Mouse pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CYP2A4 mRNA CTD PMID:27413110 Cyp2a4 Mouse quercetin decreases activity EXP 6480464 Quercetin results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse quinidine decreases activity EXP 6480464 Quinidine results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Dietary Fats affects the expression of CYP2A4 mRNA] CTD PMID:17086191 Cyp2a4 Mouse resveratrol decreases activity EXP 6480464 resveratrol results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse rifampicin increases expression EXP 6480464 Rifampin results in increased expression of CYP2A4 mRNA CTD PMID:30503582 Cyp2a4 Mouse senecionine increases expression EXP 6480464 senecionine results in increased expression of CYP2A4 protein CTD PMID:35357534 Cyp2a4 Mouse serpentine asbestos decreases expression EXP 6480464 Asbestos, Serpentine results in decreased expression of CYP2A4 mRNA CTD PMID:21514415 Cyp2a4 Mouse serpentine asbestos multiple interactions EXP 6480464 SPP1 gene mutant form inhibits the reaction [Asbestos, Serpentine results in decreased expression of CYP2A4 more ... CTD PMID:21514415 Cyp2a4 Mouse sodium arsenite multiple interactions EXP 6480464 [Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of CYP2A4 mRNA; sodium arsenite promotes more ... CTD PMID:16452187|PMID:19665456 Cyp2a4 Mouse sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CYP2A4 mRNA CTD PMID:14691202|PMID:17350061|PMID:17451858 Cyp2a4 Mouse sodium arsenite affects expression EXP 6480464 sodium arsenite affects the expression of CYP2A4 mRNA CTD PMID:16507464 Cyp2a4 Mouse streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of CYP2A4 more ... CTD PMID:33484791 Cyp2a4 Mouse tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of CYP2A4 mRNA CTD PMID:25123088 Cyp2a4 Mouse tamoxifen decreases activity EXP 6480464 Tamoxifen results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse testosterone increases metabolic processing EXP 6480464 CYP2A4 protein results in increased metabolism of Testosterone CTD PMID:10490589 Cyp2a4 Mouse testosterone affects metabolic processing ISO RGD:2465 6480464 CYP2A3 protein affects the metabolism of Testosterone CTD PMID:15879494 Cyp2a4 Mouse testosterone multiple interactions ISO RGD:1353273 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CYP2A7 mRNA CTD PMID:21592394 Cyp2a4 Mouse testosterone increases expression ISO RGD:1353273 6480464 Testosterone results in increased expression of CYP2A7 mRNA CTD PMID:21592394 Cyp2a4 Mouse testosterone decreases activity EXP 6480464 Testosterone results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse Testosterone propionate affects expression EXP 6480464 Testosterone Propionate affects the expression of CYP2A4 CTD PMID:20943812 Cyp2a4 Mouse tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of CYP2A4 mRNA CTD PMID:28973375 Cyp2a4 Mouse tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP2A4 mRNA CTD PMID:29987408 Cyp2a4 Mouse tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of CYP2A4 mRNA CTD PMID:16917069 Cyp2a4 Mouse thioacetamide increases expression ISO RGD:2465 6480464 Thioacetamide results in increased expression of CYP2A3 mRNA CTD PMID:23411599 Cyp2a4 Mouse titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CYP2A4 mRNA CTD PMID:23557971 Cyp2a4 Mouse titanium dioxide decreases expression ISO RGD:2465 6480464 titanium dioxide results in decreased expression of CYP2A3 mRNA CTD PMID:30012374 Cyp2a4 Mouse triclosan decreases expression ISO RGD:1353273 6480464 Triclosan results in decreased expression of CYP2A7 mRNA CTD PMID:30510588 Cyp2a4 Mouse Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of CYP2A4 mRNA CTD PMID:32835833 Cyp2a4 Mouse troglitazone decreases expression ISO RGD:1353273 6480464 Troglitazone results in decreased expression of CYP2A7 mRNA CTD PMID:25572481 Cyp2a4 Mouse tungsten multiple interactions ISO RGD:2465 6480464 [Nickel co-treated with Cobalt co-treated with Tungsten] results in decreased expression of CYP2A3 mRNA; [Nickel more ... CTD PMID:22198552 Cyp2a4 Mouse valproic acid multiple interactions ISO RGD:1353273 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of CYP2A7 mRNA CTD PMID:17183730 Cyp2a4 Mouse valproic acid increases expression ISO RGD:2465 6480464 Valproic Acid results in increased expression of CYP2A3 mRNA CTD PMID:35594946 Cyp2a4 Mouse verapamil decreases activity EXP 6480464 Verapamil results in decreased activity of CYP2A4 protein CTD PMID:18420780 Cyp2a4 Mouse warfarin decreases activity EXP 6480464 Warfarin results in decreased activity of CYP2A4 protein CTD PMID:18420780
Molecular Function
Only show annotations with direct experimental evidence (0 objects hidden)
Cyp2a4 Mouse arachidonate epoxygenase activity enables IBA PANTHER:PTN002549507|RGD:620088 2290270 GO_Central GO_REF:0000033 Cyp2a4 Mouse coumarin 7-hydroxylase activity enables ISO UniProtKB:P11509 2290270 GO_Central GO_REF:0000119 Cyp2a4 Mouse enzyme binding enables ISO UniProtKB:P11509 2290270 GO_Central GO_REF:0000119 Cyp2a4 Mouse heme binding enables IBA PANTHER:PTN000670347|UniProtKB:P10635|UniProtKB:P05181|UniProtKB:P11509|UniProtKB:P20813|UniProtKB:Q6VVX0|UniProtKB:P33261|UniProtKB:Q16696 2290270 GO_Central GO_REF:0000033 Cyp2a4 Mouse heme binding enables ISO UniProtKB:P11509|UniProtKB:Q16696 2290270 GO_Central GO_REF:0000119 Cyp2a4 Mouse heme binding enables IEA InterPro:IPR001128|InterPro:IPR002401|InterPro:IPR008067|InterPro:IPR036396 2290270 InterPro GO_REF:0000002 Cyp2a4 Mouse iron ion binding enables IEA InterPro:IPR001128|InterPro:IPR002401|InterPro:IPR008067|InterPro:IPR017972|InterPro:IPR036396 2290270 InterPro GO_REF:0000002 Cyp2a4 Mouse oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen enables IEA EC:1.14.14.1 2290270 UniProt GO_REF:0000003 Cyp2a4 Mouse oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen enables IBA PANTHER:PTN000670347|UniProtKB:P33261|UniProtKB:Q7Z449|UniProtKB:P05181|UniProtKB:P24903 2290270 GO_Central GO_REF:0000033 Cyp2a4 Mouse oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen enables IEA RHEA:17149 2290270 RHEA GO_REF:0000116
Imported Annotations - SMPDB
Imported Annotations - KEGG (archival)
(-)-anisomycin (EXP) (1->4)-beta-D-glucan (EXP) (S)-nicotine (ISO) 1,2-dimethylhydrazine (EXP) 17beta-estradiol (EXP,ISO) 1H-pyrazole (ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (EXP) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile (EXP) 3-methylcholanthrene (EXP,ISO) 4,4'-sulfonyldiphenol (EXP) 5-aza-2'-deoxycytidine (EXP) 5-methoxyindole (EXP) aflatoxin B1 (ISO) alachlor (ISO) all-trans-retinoic acid (EXP) ammonium chloride (ISO) andrographolide (EXP) Aroclor 1254 (ISO) arsane (EXP) arsenic atom (EXP) arsenite(3-) (EXP) atrazine (EXP) benzene (EXP) benzo[a]pyrene (EXP,ISO) beta-naphthoflavone (EXP) bis(2-ethylhexyl) phthalate (EXP) bisphenol A (EXP,ISO) bisphenol F (EXP) C60 fullerene (ISO) caffeine (EXP) calcitriol (ISO) carbon nanotube (EXP) chlorohydrocarbon (ISO) cholesterol (EXP) cholic acid (EXP) cobalt atom (ISO) cyclophosphamide (EXP) cyclosporin A (ISO) cylindrospermopsin (EXP) cypermethrin (ISO) daidzein (EXP) dextromethorphan (EXP) dibenzofurans (EXP) dichloroacetic acid (EXP) diclofenac (EXP) diethylstilbestrol (EXP) dihydroergotamine (EXP) diquat (EXP) doramapimod (EXP) endosulfan (ISO) epoxiconazole (EXP) ethanol (EXP,ISO) farnesol (ISO) fenofibrate (ISO) fipronil (ISO) fumonisin B1 (EXP) furan (EXP) glyphosate (EXP) griseofulvin (EXP) hexachlorobenzene (ISO) hydralazine (ISO) isoproturon (EXP) ivermectin (EXP) ketoconazole (EXP) Lasiocarpine (ISO) lithocholic acid (EXP) lycopene (EXP) MeIQx (ISO) mephenytoin (EXP) methotrexate (EXP) methoxsalen (EXP,ISO) methoxychlor (EXP) methylmercury chloride (ISO) midazolam (EXP) N,N-diethyl-m-toluamide (ISO) N-nitrosodiethylamine (ISO) N-nitrosodimethylamine (ISO) N-Nitrosopyrrolidine (ISO) nickel atom (ISO) nicotine (ISO) nifedipine (EXP) O-methyleugenol (ISO) okadaic acid (ISO) paraquat (ISO) parathion (EXP) pentane-2,3-dione (ISO) perfluorooctane-1-sulfonic acid (EXP) perfluorooctanoic acid (EXP) phenobarbital (EXP,ISO) pirinixic acid (EXP) potassium dichromate (EXP) pregnenolone 16alpha-carbonitrile (EXP) quercetin (EXP) quinidine (EXP) resveratrol (EXP) rifampicin (EXP) senecionine (EXP) serpentine asbestos (EXP) sodium arsenite (EXP) streptozocin (EXP) tamoxifen (EXP) testosterone (EXP,ISO) Testosterone propionate (EXP) tetrachloroethene (EXP) tetrachloromethane (EXP) tetracycline (EXP) thioacetamide (ISO) titanium dioxide (EXP,ISO) triclosan (ISO) Triptolide (EXP) troglitazone (ISO) tungsten (ISO) valproic acid (ISO) verapamil (EXP) warfarin (EXP)
Cyp2a4 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 7 26,006,617 - 26,014,513 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 7 26,006,594 - 26,014,513 (+) Ensembl GRCm39 Ensembl GRCm38 7 26,307,192 - 26,315,088 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 7 26,307,169 - 26,315,088 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 7 27,092,211 - 27,100,107 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 7 26,015,952 - 26,023,848 (+) NCBI MGSCv36 mm8 Celera 7 20,896,679 - 20,902,855 (+) NCBI Celera Cytogenetic Map 7 A3 NCBI cM Map 7 14.39 NCBI
CYP2A7 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 19 40,875,439 - 40,882,231 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 19 40,875,439 - 40,882,752 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 19 41,381,344 - 41,388,136 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 19 46,073,184 - 46,080,497 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 19 46,073,183 - 46,080,497 NCBI Celera 19 38,181,466 - 38,188,779 (-) NCBI Celera Cytogenetic Map 19 q13.2 NCBI HuRef 19 37,814,479 - 37,821,742 (-) NCBI HuRef CHM1_1 19 41,381,111 - 41,388,380 (-) NCBI CHM1_1 T2T-CHM13v2.0 19 43,696,148 - 43,702,882 (-) NCBI T2T-CHM13v2.0
Cyp2a3 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 91,299,584 - 91,307,650 (+) NCBI GRCr8 mRatBN7.2 1 82,171,914 - 82,179,980 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 82,169,949 - 82,179,979 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 87,588,938 - 87,597,006 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 96,075,221 - 96,083,279 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 89,344,793 - 89,352,861 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 83,653,248 - 83,662,118 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 83,653,234 - 83,766,484 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 84,869,280 - 84,876,600 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 81,944,896 - 81,953,007 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 82,023,006 - 82,030,923 (+) NCBI Celera 1 76,591,113 - 76,599,123 (+) NCBI Celera Cytogenetic Map 1 q21 NCBI
.
Predicted Target Of
Count of predictions: 69 Count of miRNA genes: 67 Interacting mature miRNAs: 68 Transcripts: ENSMUST00000098657 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
1300722 Sle3_m systemic lupus erythmatosus susceptibility 3 (mouse) Not determined 7 3511728 87142720 Mouse 25314307 Mlh1fc2_m MLH1 foci count 2 (mouse) 7 6502999 133501729 Mouse 4141566 Femwf8_m femur work to failure 8 (mouse) Not determined 13032485 47032621 Mouse 1301041 Prnr2_m prion resistance 2 (mouse) Not determined 7 18728794 39674033 Mouse 12904742 Litsq2_m litter size QTL 2 (mouse) 7 22673887 56674033 Mouse 1301622 Eae12_m susceptibility to experimental allergic encephalomyelitis 12 (mouse) Not determined 7 19280015 53280104 Mouse 11354952 Pdcc1_m plasmacytoid dentritic cell compartment 1 (mouse) 7 23066531 57066531 Mouse 38501068 Tip1_m tuberculosis immunophenotype 1, spleen CFU (mouse) 7 3602999 72549748 Mouse 25314314 Sccor1_m synaptonemal complex length to mean MLH1 count ratio 1 (mouse) 7 13333925 47349748 Mouse 10449139 Eosn1_m eosinophil differential 1 (mouse) 7 12480877 46480877 Mouse 1301052 Bhr6_m bronchial hyperresponsiveness 6 (mouse) Not determined 7 19842250 53842367 Mouse 11522751 Cocia17_m cocaine-induced activity, QTL 17 (mouse) 7 13135204 47135204 Mouse 12792978 Fbmd3_m femoral bone mineral density 3, females only (mouse) 7 7050288 142367832 Mouse 1301158 Eae4_m susceptibility to experimental allergic encephalomyelitis 4 (mouse) Not determined 7 19147398 141919804 Mouse 1301572 Sluc30_m susceptibility to lung cancer 30 (mouse) Not determined 7 2431696 36431844 Mouse 1357699 Nhdlq6_m non-HDL QTL 6 (mouse) Not determined 7 9988867 43988984 Mouse 10449158 Eosn3_m eosinophil differential 3 (mouse) 7 12480877 46480877 Mouse 10412199 Sst2_m susceptibility to tuberculosis 2 (mouse) Not determined 7 18728794 119485380 Mouse 1558893 Spir1_m Streptococcus pneumoniae infection resistance 1 (mouse) Not determined 7 10305798 44305936 Mouse 1301709 Bdt4_m bone density traits 4 (mouse) Not determined 7 22888572 56888716 Mouse 1559016 Drsi_m DCC-related Spp1 induction (mouse) Not determined 7 16637293 49159331 Mouse
AI893559
Mouse Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 7 A3 UniSTS cM Map 7 6.5 UniSTS cM Map 7 6.5 UniSTS Whitehead/MRC_RH 7 347.01 UniSTS
D17973
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 7 26,843,095 - 26,843,205 UniSTS GRCm38 MGSCv37 7 27,628,114 - 27,628,224 UniSTS GRCm37 Celera 7 21,423,796 - 21,423,906 UniSTS Cytogenetic Map 7 A3 UniSTS cM Map 7 6.5 UniSTS cM Map 7 6.5 UniSTS Whitehead_YAC 7 UniSTS
J03549
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 7 26,952,382 - 26,952,488 UniSTS GRCm38 GRCm38 7 26,314,919 - 26,315,025 UniSTS GRCm38 MGSCv37 7 27,737,401 - 27,737,507 UniSTS GRCm37 MGSCv37 7 27,099,938 - 27,100,044 UniSTS GRCm37 Celera 7 20,902,686 - 20,902,792 UniSTS Celera 7 21,523,846 - 21,523,952 UniSTS Cytogenetic Map 7 A3 UniSTS cM Map 7 6.5 UniSTS Whitehead/MRC_RH 7 331.37 UniSTS
Cyp2a4
Mouse Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 7 A3 UniSTS cM Map 7 6.5 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
Ensembl Acc Id:
ENSMUST00000098657 ⟹ ENSMUSP00000096254
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 7 26,006,594 - 26,014,513 (+) Ensembl GRCm38.p6 Ensembl 7 26,307,169 - 26,315,088 (+) Ensembl
RefSeq Acc Id:
NM_009997 ⟹ NP_034127
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 7 26,006,617 - 26,014,513 (+) NCBI GRCm38 7 26,307,192 - 26,315,088 (+) ENTREZGENE MGSCv37 7 27,092,211 - 27,100,107 (+) RGD Celera 7 20,896,679 - 20,902,855 (+) RGD cM Map 7 ENTREZGENE
Sequence:
TGTCTGTCTATCACCCCACTGCCACCATGCTGACCTCAGGACTCCTCCTGGTGGCTGCAGTGGCCTTCCTCAGCGTCCTGGTTTTGATGTCTGTCTGGAAGCAGAGAAAGCTCTCAGGAAAGCTGCCT CCAGGACCCACCCCACTGCCCTTCGTTGGGAACTTCCTTCAGCTGAACACAGAGCAAATGTACAACTCTCTCATGAAGATCAGCCAACGTTATGGTCCTGTATTCACCATCTATCTGGGATCTCGCCG AATTGTGGTGCTGTGCGGACAGGAGACAGTCAAGGAAGCTCTGGTGGACCAAGCTGAGGAATTCAGCGGGCGGGGCGAGCAGGCTACCTTCGACTGGCTTTTCAAAGGCTATGGCATAGCCTTCAGCA GCGGGGAGCGAGCCAAACAGCTAAGGCGCTTCTCCATCACCACGCTGCGGGACTTCGGCGTGGGGAAGCGTGGCATCGAGGAGCGCATCCAAGAGGAGGCGGGCTTTCTCATCGATTCATTTCGGAAG ACGAACGGTGCTTTCATTGACCCCACCTTCTACCTTAGCCGAACAGTCTCCAATGTCATTAGCTCAATCGTCTTCGGGGACCGCTTTGACTATGAGGACAAAGAGTTCCTGTCACTTCTTAGAATGAT GCTGGGAAGCCTCCAGTTCACTGCTACCTCCATGGGGCAGGTCTATGAGATGTTTTCTTCTGTGATGAAACACCTGCCAGGGCCCCAGCAACAGGCCTTTAAGGAGCTGCAAGGCCTGGAGGACTTTA TAACCAAGAAAGTGGAACACAATCAGCGCACGCTGGATCCCAATTCCCCAAGGGACTTCATCGACTCCTTCCTCATCCGAATGCTGGAGGAGAAGAAGAACCCCAATACTGAGTTCTACATGAAGAAC TTGGTGCTGACTACACTAAATCTCTTCTTTGCTGGCACAGAGACCGTCAGCACCACCCTGCGCTATGGCTTTCTGTTGCTCATGAAGTACCCAGATATTGAGGCCAAGGTCCATGAGGAGATTGATCG GGTGATTGGCAGGAACCGGCAGCCCAAGTATGAGGACCGAATGAAGATGCCCTATACGGAGGCTGTAATCCATGAGATCCAGAGATTTGCAGACCTGATCCCCATGGGCCTGGCTCGAAGGGTCACCA AGGACACCAAGTTTCGAGATTTCCTCCTCCCCAAGGGTACTGAAGTATTTCCTATGCTGGGCTCTGTGCTGAAAGACCCCAAGTTCTTCTCCAACCCCAAAGACTTCAACCCAAAGCACTTCCTAGAT GACAAGGGACAGTTTAAGAAGAGTGATGCCTTTGTGCCCTTTTCCATTGGAAAACGGTATTGTTTCGGAGAAGGACTGGCTAGGATGGAACTCTTCCTCTTCCTCACAAACATCATGCAGAACTTCCA CTTCAAATCCACACAGGAACCCCAGGACATCGATGTGTCTCCTAGACTCGTGGGCTTTGTCACGATCCCACCAACCTACACTATGAGTTTCTTGTCCCGTTGATCCTGGGCTGCATGAGGTTAAAGGG AATGATTGAGACCAGACAAGTCAGGGGTTGAAACTTAGAAAAGGTCAAAGGTACAGAAGAAACAGAGGACACTTCGTAGACTTGCAGAGGATATTTCAAAGGTAGCCAGAGAAGGGGGAAATTATACT ATGTTGTCAATAGGAATAATAAAATAATAAAAGTAGATATTATTTATGGCA
hide sequence
RefSeq Acc Id:
NP_034127 ⟸ NM_009997
- UniProtKB:
P20852 (UniProtKB/Swiss-Prot), Q91XG2 (UniProtKB/Swiss-Prot), P15392 (UniProtKB/Swiss-Prot), Q80XK1 (UniProtKB/TrEMBL)
- Sequence:
MLTSGLLLVAAVAFLSVLVLMSVWKQRKLSGKLPPGPTPLPFVGNFLQLNTEQMYNSLMKISQRYGPVFTIYLGSRRIVVLCGQETVKEALVDQAEEFSGRGEQATFDWLFKGYGIAFSSGERAKQLR RFSITTLRDFGVGKRGIEERIQEEAGFLIDSFRKTNGAFIDPTFYLSRTVSNVISSIVFGDRFDYEDKEFLSLLRMMLGSLQFTATSMGQVYEMFSSVMKHLPGPQQQAFKELQGLEDFITKKVEHNQ RTLDPNSPRDFIDSFLIRMLEEKKNPNTEFYMKNLVLTTLNLFFAGTETVSTTLRYGFLLLMKYPDIEAKVHEEIDRVIGRNRQPKYEDRMKMPYTEAVIHEIQRFADLIPMGLARRVTKDTKFRDFL LPKGTEVFPMLGSVLKDPKFFSNPKDFNPKHFLDDKGQFKKSDAFVPFSIGKRYCFGEGLARMELFLFLTNIMQNFHFKSTQEPQDIDVSPRLVGFVTIPPTYTMSFLSR
hide sequence
Ensembl Acc Id:
ENSMUSP00000096254 ⟸ ENSMUST00000098657
RGD ID: 6892318
Promoter ID: EPDNEW_M9610
Type: single initiation site
Name: Cyp2a4_1
Description: Mus musculus cytochrome P450, family 2, subfamily a, polypeptide4 , mRNA.
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Mouse Assembly Chr Position (strand) Source GRCm38 7 26,307,193 - 26,307,253 EPDNEW
RGD ID: 6840902
Promoter ID: MM_KWN:49493
Type: Non-CpG
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: Liver
Transcripts: NM_009997
Position: Mouse Assembly Chr Position (strand) Source MGSCv36 7 27,092,111 - 27,092,611 (+) MPROMDB